Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 25083741)

1.

Repurposing cAMP-modulating medications to promote β-cell replication.

Zhao Z, Low YS, Armstrong NA, Ryu JH, Sun SA, Arvanites AC, Hollister-Lock J, Shah NH, Weir GC, Annes JP.

Mol Endocrinol. 2014 Oct;28(10):1682-97. doi: 10.1210/me.2014-1120. Epub 2014 Aug 1.

PMID:
25083741
2.

Cyclic AMP-adenosine pathway inhibits vascular smooth muscle cell growth.

Dubey RK, Mi Z, Gillespie DG, Jackson EK.

Hypertension. 1996 Nov;28(5):765-71.

3.

Spatiotemporal dynamics of beta-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases.

Leroy J, Abi-Gerges A, Nikolaev VO, Richter W, Lechêne P, Mazet JL, Conti M, Fischmeister R, Vandecasteele G.

Circ Res. 2008 May 9;102(9):1091-100. doi: 10.1161/CIRCRESAHA.107.167817. Epub 2008 Mar 27.

4.
5.
6.

Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.

Mehel H, Emons J, Vettel C, Wittköpper K, Seppelt D, Dewenter M, Lutz S, Sossalla S, Maier LS, Lechêne P, Leroy J, Lefebvre F, Varin A, Eschenhagen T, Nattel S, Dobrev D, Zimmermann WH, Nikolaev VO, Vandecasteele G, Fischmeister R, El-Armouche A.

J Am Coll Cardiol. 2013 Oct 22;62(17):1596-606. doi: 10.1016/j.jacc.2013.05.057. Epub 2013 Jun 26.

7.

β2-adrenergic receptor-coupled phosphoinositide 3-kinase constrains cAMP-dependent increases in cardiac inotropy through phosphodiesterase 4 activation.

Gregg CJ, Steppan J, Gonzalez DR, Champion HC, Phan AC, Nyhan D, Shoukas AA, Hare JM, Barouch LA, Berkowitz DE.

Anesth Analg. 2010 Oct;111(4):870-7. doi: 10.1213/ANE.0b013e3181ee8312. Epub 2010 Aug 12.

PMID:
20705779
8.
9.
10.

Mechanism of catecholamine-mediated destabilization of messenger RNA encoding Thy-1 protein in T-lineage cells.

Wajeman-Chao SA, Lancaster SA, Graf LH Jr, Chambers DA.

J Immunol. 1998 Nov 1;161(9):4825-33.

11.

Adenosine--norepinephrine interactions on cyclic AMP generating system in human tumoral brain slices.

Caciagli F, Ciccarelli R, Ciancetta S, Di Iorio P, Caciagli P.

Int J Tissue React. 1982;4(3):233-41.

PMID:
6292078
13.

Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture.

Leicht M, Greipel N, Zimmer H.

Cardiovasc Res. 2000 Nov;48(2):274-84.

14.

Stress and glucocorticoids impair memory retrieval via β2-adrenergic, Gi/o-coupled suppression of cAMP signaling.

Schutsky K, Ouyang M, Castelino CB, Zhang L, Thomas SA.

J Neurosci. 2011 Oct 5;31(40):14172-81. doi: 10.1523/JNEUROSCI.2122-11.2011.

15.

Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation.

Zhuplatov SB, Masaki T, Blumenthal DK, Cheung AK.

Basic Clin Pharmacol Toxicol. 2006 Dec;99(6):431-9.

PMID:
17169124
16.

Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling.

Nikolaev VO, Bünemann M, Schmitteckert E, Lohse MJ, Engelhardt S.

Circ Res. 2006 Nov 10;99(10):1084-91. Epub 2006 Oct 12.

17.

'Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart.

Pepe S, Xiao RP, Hohl C, Altschuld R, Lakatta EG.

Circulation. 1997 Apr 15;95(8):2122-9.

18.

Factors influencing the effect of hormones on the accumulation of cyclic AMP in cultured human astrocytoma cells.

Clark RB, Su YF, Ortmann R, Cubeddu L, Johnson GL, Perkins JP.

Metabolism. 1975 Mar;24(3):343-58.

PMID:
165356
19.
20.

Different effects of adenylyl cyclase activators and phosphodiesterases inhibitors on cervical cancer (HeLa) and breast cancer (MCF-7) cells proliferation.

Mahdian D, Shafiee-Nick R, Mousavi SH.

Toxicol Mech Methods. 2014 May;24(4):307-14. doi: 10.3109/15376516.2014.898354. Epub 2014 Mar 19.

PMID:
24593874
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk